Guideline on registry-based studies | European Medicines Agency

Guideline on registry-based studies | European Medicines Agency The European Medicines Agency has published guidance on registry-based studies to which EURORDIS has contributed, providing key methods and regulatory practices to pharmaceutical companies for the planning and conduct of registry-based studies.